PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea · Delayed Price · Currency is KRW

302,000

+5,000 (1.68%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			261.01B	194.76B	154.08B	108.75B	83.87B
Pharmaceuticals Growth			34.02%	26.40%	41.69%	29.66%	30.48%
Total			261.01B	194.76B	154.08B	108.75B	83.87B
Total Growth			34.02%	26.40%	41.69%	29.66%	30.48%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			170.07B	138.65B	111.60B	83.64B	66.03B
South Korea Growth			22.66%	24.25%	33.42%	26.67%	23.32%
Overseas			90.94B	56.10B	42.49B	25.10B	17.84B
Overseas Growth			62.09%	32.05%	69.24%	40.71%	66.19%
Total			261.01B	194.76B	154.08B	108.75B	83.87B
Total Growth			34.02%	26.40%	41.69%	29.66%	30.48%

Source: S&P Global Market Intelligence.